Plasminogen activation in multiple sclerosis and other neurological disorders
- 1 January 2000
- journal article
- Published by Elsevier in Fibrinolysis and Proteolysis
- Vol. 14 (1) , 1-14
- https://doi.org/10.1054/fipr.2000.0056
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial diseaseAtherosclerosis, 1995
- Tissue-type plasminogen activator (tPA) is the main plasminogen activator associated with isolated rat nerve growth conesNeuroscience Letters, 1994
- Plasminogen activator inhibitor-1 in the cerebrospinal fluid as an index of neurological diseaseBlood Coagulation & Fibrinolysis, 1994
- Cytokine-regulated proteases in autoimmune diseasesImmunology Today, 1994
- Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: Localisation of GD3 ganglioside immunoreactivityJournal of Neuroscience Research, 1993
- The role of reactive oxygen species in the pathogenesis of multiple sclerosisMedical Hypotheses, 1992
- Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six monthsAnnals of Neurology, 1989
- Type 1 Plasminogen Activator Inhibitor and Its Potential Influence on Thrombolytic TherapySeminars in Thrombosis and Hemostasis, 1988
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Low molecular solutes and the blood cerebrospinal fluid barrierJournal of Molecular Medicine, 1982